Large-scale testing (Phase 3)Not Yet RecruitingNCT06333821
What this trial is testing
Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma
Who this might be right for
Cervical Cancer
Biotech Pharmaceutical Co., Ltd. 460